Caplin Point Labs Gets Colombia Regulatory Approval for Softgel Capsules
May 06, 2024 13:16
Caplin Point Labs receives regulatory approval from Colombia's INVIMA for its softgel capsules division in Puducherry, expanding its reach in Latin America.
New Delhi, May 6 (PTI) Caplin Point Laboratories Ltd on Monday said it has received approval from Colombia's regulatory body, INVIMA for its softgel capsules division at Puducherry.
The approval follows site inspection of Unit-1, which was completed on May 3 and found compliant as per INVlMA's norms of Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP), Caplin Point Laboratories said in a regulatory filing.
The unit currently caters to emerging markets of Latin America and Africa with a variety of dosage forms such as tablets, capsules, softgel capsules, suppositories, liquid orals, topicals and injectables, it added.
"Expansion into larger markets of Latin America such as Colombia, is an important aspect of our future growth, and this approval, especially in the niche Softgel Capsules range will contribute well to the same," Caplin Point Laboratories Chairman CC Paarthipan said.
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.